If prescribed, your treatment plan may include injection instructions, dose guidance, supplies, follow-up support, and pharmacy coordination
9,10 Summary A large body of high-quality evidence suggests that in patients with obesity without diabetes, GLP-1 and GIP/GLP-1 receptor agonists are associated with significant regain of lost weight after therapy discontinuation
These endorsements are often the deciding factor for strong and competitive applications and are necessary components for programs like the US Air Forces AFWERX Direct-to-Phase II Open Topic
Studies on pregnant animals showed some concerning results: Smaller baby sizes Birth defects in bones and organs Higher rates of miscarriage Problems with baby growth The FDA puts semaglutide and tirzepatide in pregnancy category C. This means we cant rule out risks to a developing baby
Resume your regular schedule: Once you've either taken the missed dose or skipped it, continue with your normal weekly dosing schedule
Dual classification = supply-chain robustness through regulatory transitions